News & Blog

We are delighted to welcome Dr. Ioanna Nixon to Gena Health as a Clinical Advisor

· Gena Health Team

Ioanna is a Consultant Clinical Oncologist specialising in uro-oncology and an Honorary Clinical Senior Lecturer at the University of Glasgow, with more than 20 years’ experience spanning cancer care, research, innovation and healthcare leadership.

Her career combines frontline oncology with leadership at organisational and national level. She has served as National Clinical Lead for the Scottish Sarcoma Network, Clinical Director of Oncology at NHS Greater Glasgow & Clyde, and Chair of the NCRI Head & Neck Epidemiology and Survivorship Group, alongside leadership roles in cancer innovation, quality improvement and service transformation.

Across these roles, Ioanna has worked at the intersection of clinical care, patient experience and healthcare systems, with a strong track record of translating evidence and innovation into real-world practice and co-designing services and initiatives with patients.

At Gena, she will bring this clinical, patient and systems perspective to the development of technology designed to help oncology teams and patients navigate increasingly complex information and treatment decisions. 

Quote from Dr. Ioanna Nixon:

“Cancer care is becoming increasingly complex. The opportunity is not simply to give clinicians and patients more information, but to make the right information easier to navigate and act on. I’m excited to work with Gena to help build technology that supports clinical judgement and keeps the individual patient at the centre.”

Quote from Skomer Bennett Clemmow, CEO and Co-Founder, Gena Health:

“Ioanna brings an invaluable perspective on how we ensure the patient voice is embedded from the outset in cancer care - helping to shape our consultation interface so that patients’ priorities, concerns and preferences are captured meaningfully and carried into clinical decision-making, including how we bring patients more directly into the MDT process.”

Ioanna’s appointment further strengthens Gena Health’s commitment to building technology around the realities of both clinical practice and patient experience. By combining her expertise in oncology, healthcare systems and patient-centred care, she will help ensure that Gena’s tools support better consultations, richer MDT discussions and decisions that reflect not only the clinical picture, but what matters most to each patient.